Your browser doesn't support javascript.
loading
Blood-brain barrier dysfunction and reduced cerebrospinal fluid levels of soluble amyloid precursor protein-ß in patients with subcortical small-vessel disease.
Kettunen, Petronella; Bjerke, Maria; Eckerström, Carl; Jonsson, Michael; Zetterberg, Henrik; Blennow, Kaj; Svensson, Johan; Wallin, Anders.
Afiliação
  • Kettunen P; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy University of Gothenburg Gothenburg Sweden.
  • Bjerke M; Laboratory of Neurochemistry, Department of Clinical Biology and Center for Neurosciences Universitair Ziekenhuis Brussel Brussels Belgium.
  • Eckerström C; Department of Biomedical Sciences Institute Born-Bunge University of Antwerp Antwerp Belgium.
  • Jonsson M; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy University of Gothenburg Gothenburg Sweden.
  • Zetterberg H; Department of Immunology and Transfusion Medicine Sahlgrenska University Hospital Gothenburg Sweden.
  • Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy University of Gothenburg Gothenburg Sweden.
  • Svensson J; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy University of Gothenburg Gothenburg Sweden.
  • Wallin A; Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Mölndal Sweden.
Alzheimers Dement (Amst) ; 14(1): e12296, 2022.
Article em En | MEDLINE | ID: mdl-35356486

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article